Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of Schizophrenia
Clinical trial NCT06574360 · RECRUITING
Trial details
- NCT number
- NCT06574360
- Sponsor
- China Medical University Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-23
- Primary completion
- 2028-12-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.